Countagen develops cutting-edge gene editing analysis tools to enable and accelerate access to the transformative power of gene editing. Our mission is to pioneer excellence in the development and discovery of gene and cell therapies.

GeneAbacus, our flagship product, utilizes the unique technology of padlock probes and rolling circle amplification to speed up and simplify the gene targeting validation process. This assay removes the need for PCR and can be done completely in-house with standard laboratory instrumentation. We are able to bring extracted DNA to quantified data in under 5 hours, with minimal hands-on time and digital quantification precision.

Our goal is to ensure that every insight derived from our products is grounded in accuracy and reliability, driving our mission to simplify, accelerate, and improve quality control within gene editing.